Literature DB >> 15342369

Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.

Peter K Cheung1, Bruce Woolcock, Hans Adomat, Margaret Sutcliffe, Terry C Bainbridge, Edward C Jones, Douglas Webber, Thomas Kinahan, Marianne Sadar, Martin E Gleave, Juergen Vielkind.   

Abstract

Identification of proteomic alterations associated with early stages in the development of prostate cancer may facilitate understanding of progression of this highly variable disease. Matched normal, high-grade prostatic intraepithelial neoplasia (hPIN) and prostate cancer cells of predominantly Gleason grade 3 were procured by laser capture microdissection from serial sections obtained from snap-frozen samples dissected from 22 radical prostatectomy specimens. From these cells, protein profiles were generated by surface-enhanced laser desorption/ionization-time of flight mass spectrometry. A 24-kDa peak was observed at low or high intensity in profiles of prostate cancer cells in 19 of 27 lesions and at low intensity in 3 of 8 hPIN lesions but was not detectable in matched normal cells. SDS-PAGE analysis of prostate cancer and matched normal epithelium confirmed expression of a prostate cancer-specific 24-kDa protein. Mass spectrometry and protein data-based analysis identified the protein as the dimeric form of mature growth differentiation factor 15 (GDF15). The increased expression of mature GDF15 protein in prostate cancer cells cannot be explained on the basis of up-regulation of GDF15 mRNA because reverse transcription-PCR analysis showed similar amounts of transcript in normal, hPIN, and prostate cancer cells that were obtained by laser capture microdissection in the same set of serial sections from which the protein profiles were obtained. Our findings suggest that early prostate carcinogenesis is associated with expression of mature GDF15 protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342369     DOI: 10.1158/0008-5472.CAN-04-1216

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review.

Authors:  Manfred Dietel; Christine Sers
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

Review 2.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

Review 3.  [The significance of chronic prostatitis for the etiopathology of prostate cancer].

Authors:  D Wittschieber; S Schenkenberg; M Dietel; A Erbersdobler
Journal:  Urologe A       Date:  2010-08       Impact factor: 0.639

Review 4.  The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.

Authors:  Rhonda L Bitting; Daneen Schaeffer; Jason A Somarelli; Mariano A Garcia-Blanco; Andrew J Armstrong
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 5.  Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

6.  Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury.

Authors:  Jing Liu; Sanjeev Kumar; Andreas Heinzel; Michael Gao; Jinjin Guo; Gregory F Alvarado; Roman Reindl-Schwaighofer; A Michaela Krautzberger; Pietro E Cippà; Jill McMahon; Rainer Oberbauer; Andrew P McMahon
Journal:  J Am Soc Nephrol       Date:  2020-02-07       Impact factor: 10.121

Review 7.  Molecular pathology of prostate cancer.

Authors:  C Hughes; A Murphy; C Martin; O Sheils; J O'Leary
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

8.  Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma in China: a SELDI-TOF-MS study.

Authors:  Jianzhong Zhang; Dong Li; Yanhua Zheng; Yan Cui; Kai Feng; Jinlian Zhou; Jihua Wu
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology.

Authors:  Qiaojia Huang; Qingling Huang; Wannan Chen; Lin Wang; Wansong Lin; Jianyin Lin; Xu Lin
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-30       Impact factor: 4.553

Review 10.  Biomarkers for prostate cancer.

Authors:  Eric Schiffer
Journal:  World J Urol       Date:  2007-08-10       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.